LifeMD Inc (NASDAQ: LFMD)’s stock price has increased by 4.21 compared to its previous closing price of 10.82. However, the company has seen a 16.24% increase in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-04-24 that NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on May 8, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time.
Is It Worth Investing in LifeMD Inc (NASDAQ: LFMD) Right Now?
LFMD has 36-month beta value of 1.42. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for LFMD is 31.20M, and currently, short sellers hold a 7.48% ratio of that float. The average trading volume of LFMD on April 26, 2024 was 645.33K shares.
LFMD’s Market Performance
LFMD stock saw an increase of 16.24% in the past week, with a monthly gain of 10.76% and a quarterly increase of 92.08%. The volatility ratio for the week is 5.81%, and the volatility levels for the last 30 days are 6.31% for LifeMD Inc (LFMD). The simple moving average for the last 20 days is 11.66% for LFMD stock, with a simple moving average of 68.31% for the last 200 days.
Analysts’ Opinion of LFMD
Many brokerage firms have already submitted their reports for LFMD stocks, with Craig Hallum repeating the rating for LFMD by listing it as a “Buy.” The predicted price for LFMD in the upcoming period, according to Craig Hallum is $10 based on the research report published on November 30, 2023 of the previous year 2023.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see LFMD reach a price target of $7. The rating they have provided for LFMD stocks is “Overweight” according to the report published on July 21st, 2023.
H.C. Wainwright gave a rating of “Buy” to LFMD, setting the target price at $9 in the report published on July 03rd of the previous year.
LFMD Trading at 21.92% from the 50-Day Moving Average
After a stumble in the market that brought LFMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.12% of loss for the given period.
Volatility was left at 6.31%, however, over the last 30 days, the volatility rate increased by 5.81%, as shares surge +10.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +70.16% upper at present.
During the last 5 trading sessions, LFMD rose by +17.01%, which changed the moving average for the period of 200-days by +141.49% in comparison to the 20-day moving average, which settled at $10.15. In addition, LifeMD Inc saw 36.01% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFMD starting from Velge Bertrand, who purchase 60,000 shares at the price of $3.93 back on Aug 31 ’23. After this action, Velge Bertrand now owns 349,482 shares of LifeMD Inc, valued at $235,800 using the latest closing price.
Velge Bertrand, the Director of LifeMD Inc, purchase 40,000 shares at $3.76 during a trade that took place back on Aug 30 ’23, which means that Velge Bertrand is holding 289,482 shares at $150,400 based on the most recent closing price.
Stock Fundamentals for LFMD
Current profitability levels for the company are sitting at:
- -0.09 for the present operating margin
- 0.86 for the gross margin
The net margin for LifeMD Inc stands at -0.17. The total capital return value is set at -0.61. Equity return is now at value -719.95, with -48.95 for asset returns.
Based on LifeMD Inc (LFMD), the company’s capital structure generated 0.84 points at debt to capital in total, while cash flow to debt ratio is standing at 0.47. The debt to equity ratio resting at 5.38. The interest coverage ratio of the stock is -5.58.
Currently, EBITDA for the company is -7.89 million with net debt to EBITDA at 1.8. When we switch over and look at the enterprise to sales, we see a ratio of 2.88. The receivables turnover for the company is 28.91for trailing twelve months and the total asset turnover is 2.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.22.
Conclusion
To put it simply, LifeMD Inc (LFMD) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
